Tables

TABLE 1 TRANSDERMAL DRUG DELIVERY MARKET REVENUE BY REGIONS' 2016-2023 ($MILLION) 36
TABLE 2 PROMINENT VENDORS IN THE MARKET 42
TABLE 3 NOVARTIS AG: OFFERINGS 45
TABLE 4 NOVARTIS AG: RECENT DEVELOPMENTS 45
TABLE 5 3M: OFFERINGS 51
TABLE 6 3M: RECENT DEVELOPMENTS 51
TABLE 7 JOHNSON & JOHNSON: PRODUCT OFFERINGS 56
TABLE 8 JOHNSON & JOHNSON: RECENT DEVELOPMENTS 56
TABLE 9 GLAXOSMITHKLINE PLC: OFFERINGS 63
TABLE 10 GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS 64
TABLE 11 BOEHRINGER INGELHEIM GMBH: OFFERINGS 69
TABLE 12 BOEHRINGER INGELHEIM GMBH: RECENT DEVELOPMENTS 69
TABLE 13 MYLAN N.V.: OFFERINGS 74
TABLE 14 MYLAN N.V.: RECENT DEVELOPMENTS 74
TABLE 15 ECHO THERAPEUTICS' INC.: OVERVIEW 79
TABLE 16 NOVEN PHARMACEUTICALS' INC.: OVERVIEW 79
TABLE 17 TRANSDERMAL CORP.: OVERVIEW 80
TABLE 18 BAYER AG: OVERVIEW 81
TABLE 19 BAYER AG: RECENT DEVELOPMENTS 81
TABLE 20 ACTAVIS' INC.: OVERVIEW 82
TABLE 21 CORIUM INTERNATIONAL' INC.: OVERVIEW 82
TABLE 22 CORIUM INTERNATIONAL' INC.: RECENT DEVELOPMENTS 83

?

LIST OF FIGURE

Charts
CHART 1 RESEARCH METHODOLOGY OF GLOBAL TRANSDERMAL DRUG DELIVERY MARKET 13
CHART 2 GLOBAL TRANSDERMAL DRUG DELIVERY MARKET REVENUE' 2016-2023 ($MILLION) 18
CHART 3 SEGMENTATION OF GLOBAL TRANSDERMAL DRUG DELIVERY MARKET 21
CHART 4 PORTER 5 FORCES OF TRANSDERMAL DRUG DELIVERY MARKET 21
CHART 5 PEST ANALYSIS OF TRANSDERMAL DRUG DELIVERY MARKET 22
CHART 6 MARKET DYNAMICS - DRO ANALYSIS 23
CHART 7 DRO - IMPACT ANALYSIS OF GLOBAL TRANSDERMAL DRUG DELIVERY MARKET 27
CHART 8 KEY STAKEHOLDERS 27
CHART 9 TRANSDERMAL DRUG DELIVERY MARKET SHARE BY TYPES SEGMENTATION' 2016 VS 2023 (%) 28
CHART 10 TRANSDERMAL DRUG DELIVERY PATCHES MARKET REVENUE BY TYPES SEGMENTATION' 2016-2023 ($MILLION) 29
CHART 11 TRANSDERMAL DRUG DELIVERY GELS MARKET REVENUE BY TYPES SEGMENTATION' 2016-2023 ($MILLION) 30
CHART 12 TRANSDERMAL DRUG DELIVERY MARKET SHARE BY TECHNOLOGY SEGMENTATION' 2016 (%) 31
CHART 13 TRANSDERMAL DRUG DELIVERY MARKET SHARE BY DRUG TYPE' 2016 (%) 34
CHART 14 TRANSDERMAL DRUG DELIVERY MARKET SHARE BY REGIONAL SEGMENTATION' 2016 VS 2023 (%) 36
CHART 15 TRANSDERMAL DRUG DELIVERY MARKET REVENUE IN NORTH AMERICA' 2016-2023 ($MILLION) 38
CHART 16 TRANSDERMAL DRUG DELIVERY MARKET REVENUE IN EUROPE' 2016-2023 ($MILLION) 39
CHART 17 TRANSDERMAL DRUG DELIVERY MARKET REVENUE IN ASIA PACIFIC' 2016-2023 ($MILLION) 41
CHART 18 TRANSDERMAL DRUG DELIVERY MARKET REVENUE IN REST OF THE WORLD' 2016-2023 ($MILLION) 42
CHART 19 NOVARTIS AG: OVERVIEW SNAPSHOT 47
CHART 20 NOVARTIS AG: BUSINESS UNITS 48
CHART 21 NOVARTIS AG: GEOGRAPHIC REVENUE 49
CHART 22 NOVARTIS AG: SWOT ANALYSIS 50
CHART 23 3M: OVERVIEW SNAPSHOT 52
CHART 24 3M: BUSINESS UNITS 53
CHART 25 3M: GEOGRAPHIC REVENUE 54
CHART 26 3M: SWOT ANALYSIS 56
CHART 27 JOHNSON & JOHNSON: OVERVIEW SNAPSHOT 59
CHART 28 JOHNSON & JOHNSON: BUSINESS UNITS 60
CHART 29 JOHNSON & JOHNSON: GEOGRAPHIC REVENUE 61
CHART 30 JOHNSON & JOHNSON: SWOT ANALYSIS 63
CHART 31 GLAXOSMITHKLINE PLC: OVERVIEW SNAPSHOT 66
CHART 32 GLAXOSMITHKLINE PLC: BUSINESS UNITS 66
CHART 33 GLAXOSMITHKLINE PLC: GEOGRAPHIC REVENUE 67
CHART 34 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 68
CHART 35 BOEHRINGER INGELHEIM GMBH: OVERVIEW SNAPSHOT 70
CHART 36 BOEHRINGER INGELHEIM GMBH: BUSINESS UNITS 71
CHART 37 BOEHRINGER INGELHEIM GMBH: GEOGRAPHIC REVENUE 72
CHART 38 BOEHRINGER INGELHEIM GMBH: SWOT ANALYSIS 73
CHART 39 MYLAN N.V. OVERVIEW SNAPSHOT 75
CHART 40 MYLAN N.V.: BUSINESS SEGMENTS 76
CHART 41 MYLAN N.V.: GEOGRAPHIC REVENUE 78
CHART 42 MYLAN N.V.: SWOT ANALYSIS 78